Schoof, Melanie http://orcid.org/0000-0002-1373-8130
Godbole, Shweta http://orcid.org/0000-0002-5162-5233
Albert, Thomas K. http://orcid.org/0000-0002-2488-0706
Dottermusch, Matthias http://orcid.org/0000-0002-9769-7080
Walter, Carolin
Ballast, Annika
Qin, Nan
Olivera, Marlena Baca
Göbel, Carolin http://orcid.org/0000-0002-7345-2089
Neyazi, Sina http://orcid.org/0000-0002-9861-2325
Holdhof, Dörthe http://orcid.org/0000-0003-4664-3848
Kresbach, Catena
Peter, Levke-Sophie http://orcid.org/0009-0005-7283-9061
Epplen, Gefion Dorothea
Thaden, Vanessa
Spohn, Michael
Blattner-Johnson, Mirjam
Modemann, Franziska http://orcid.org/0000-0002-5897-3310
Mynarek, Martin http://orcid.org/0000-0003-3302-2719
Rutkowski, Stefan
Sill, Martin
Varghese, Julian http://orcid.org/0000-0002-7206-3719
Afflerbach, Ann-Kristin
Eckhardt, Alicia
Münter, Daniel http://orcid.org/0000-0001-8823-0238
Verma, Archana
Struve, Nina
Jones, David T. W. http://orcid.org/0000-0002-2036-5141
Remke, Marc http://orcid.org/0000-0002-9404-9993
Neumann, Julia E. http://orcid.org/0000-0002-1162-8771
Kerl, Kornelius http://orcid.org/0000-0002-5676-8102
Schüller, Ulrich http://orcid.org/0000-0002-8731-1121
Funding for this research was provided by:
Wilhelm Sander-Stiftung
Article History
Received: 2 April 2023
Accepted: 14 November 2023
First Online: 24 November 2023
Competing interests
: F.M. received support for meeting attendance from Servier, AbbVie, Incyte, Gilead, Jazz Pharmaceuticals, Novartis, Teva, Pfizer and Amgen; received support for medical writing from Servier and Springer Verlag; received research grants from Apis Technologies, Daiichi Sankyo and received speaker honoraria from Servier, Jazz Pharmaceuticals, AbbVie, Astellas Pharma, Bristol-Myers Squibb, MSD Sharp & Dohme, Novartis, Pfizer, and Stemline Therapeutics. The remaining authors declare no competing interests.